Education and Specialization:
Hacettepe University, Faculty of Medicine, Ankara, Turkey
Fatih Sultan Mehmet Training and Research Hospital, Internal Medicine Clinic, Istanbul, Turkey, Specialty Training

Experience:
Marmara University Hospital, Specialist, Istanbul
Büyük Swisslab Clinic, General Manager, Istanbul
Istanbul Fatih Sultan Mehmet Hospital, Specialist, Istanbul
Sandıklı State Hospital, Specialist, Afyon
Universal Hospital, Specialist, Istanbul
Bayındır Hospital, Specialist, Istanbul
Yaşam Hospital, Specialist, Antalya
Medical Park Antalya Hospital Complex, Specialist, Antalya

Courses and Certifications:
Acupuncture Application Certificate
Ozone Application Certificate
Mesotherapy Application Certificate

Published Articles:

1. Küçükkaya B., Haklar G., Yalçın A.S.: NMDA excitotoxicity and free radical generation in rat brain homogenates, application of a chemiluminescence assay, Neurochem. Res., vol. 21 (12): 1533-1536, 1996.
2. Küçükkaya B., Haklar G., Yalçın A.S.: Protective effects of MK-801 and Muscimol against reactive oxygen species, Epilepsia, 37 (4): 133, 1996.
3. Kisadere G., Küçükkaya B., Güzel Ö., Yalçın A.S.: Colorimetric assay of peroxidatic activity of catalase in human erythrocytes, CCEC, 7, 359-363, 1997.
4. Küçükkaya B., Aker R., Yüksel M., Onat F., Yalçın A.S.: Low dose MK-801 protects against iron-induced oxidative changes in a rat model of focal epilepsy, Brain Res., 788: 133-136, 1998.
5. Yalçın A.S., Haklar G., Küçükkaya B., Yüksel M., Dalaman G.: Chemiluminescence measurements for the detection of free radical species, in Free radicals, oxidative stress, and antioxidants (Özben T., ed.), Plenum Press, New York, pp 385-390, 1998.
6. Yalçın A.S., Haklar G., Küçükkaya B., Yüksel M., Saybaşılı H.: The role of free radicals in NMDA and glutamate excitotoxicity, in Free radicals, oxidative stress, and antioxidants (Özben T., ed.), Plenum Press, New York, pp 189-192, 1998.
7. Yavuz D.G., Küçükkaya B., Ersöz H.O., Yalçın A.S., Emerk K., Akalın S.: Effects of Aminoguanidine on oxidative stress and nitric oxide release in diabetic rat kidneys, in Abstracts of 34th Annual Meeting of EASD, Barcelona, Spain, 8-12 Sept 1998, Diabetologia, vol 41(suppl 1), pp 1155, August 1998.
8. Yavuz D.G., Ersöz H.O., Tuncer M., Sargon M., Küçükkaya B., Ahıskalı R., Akalın S.: Effects of Aminoguanidine on glomerular basement membrane anionic content: an electron microscopic study, in Abstracts of 35th Annual Meeting of EASD, Brussels, Belgium, 28 Sept-2 Oct 1999, Diabetologia, vol 42(suppl 1), pp A275, August 1999.
9. Yavuz D.G., Ersöz H.O., Küçükkaya B., Budak Y., Ahıskalı R., Ekicioğlu G., Emerk K., Akalın S.: Effects of Losartan and captopril on glomerular basement membrane anionic charge in a diabetic rat model, Journal of Hypertension, 17(8): 1217-1221, 1999.
10. Küçükkaya B., Haklar G., Yalçın A.S.: NMDA receptor activity and its modulation by sulfhydryl compounds chemiluminescence measurements in rat brain synaptosome, Marmara Medical J., 12(2), 1999.
11. Gogas D., Küçükkaya B., Ersöz H.A., Emerk K., Akalın S.: Effects of aminoguanidine on lipid oxidation in diabetic rat kidneys, Experimental Diabetes Res., 3(2), 2002.
12. Yavuz D., Küçükkaya B., Haklar G., Ersöz Ö., Akoğlu E., Akalın S.: Effects of captopril and losartan on lipid peroxidation, protein oxidation, and nitric oxide release in diabetic rat kidney, Prost. Leu. and Fatty acids, 69(4): 223-227, 2003.
13. Sertbaş Y., Kahraman C., Küçükkaya B., Kebapçıoğlu S., Koçyıldız E., Berber E., Kuzu İ., Şendağ D.: Hemodialysis patients' pre- and post-dialysis measurements evaluated with the "TANITA" device, 7th National Internal Medicine Congress, 16-20 Sept 2005, Antalya.
14. Küçükkaya B., Sertbaş Y., Türkeri H., Berber E., Ayter M., Endin H., Aslanhan E., Şendağ D.: Distribution of CA 125 tumor marker by disease, 7th National Internal Medicine Congress, 16-20 Sept 2005, Antalya.
15. Küçükkaya B., Ekiz B., Gültekin F., Sertbaş Y., Erdem L., Şendağ D.: Effects of ezetimibe treatment on insulin resistance parameters in non-diabetic hyperlipidemic patients, 8th National Internal Medicine Congress, 13-17 Sept 2006, Antalya.
16. Sertbaş Y., Küçükkaya B., Gültekin F., Erdem L., Akıncı M., Şendağ D.: Effects of ezetimibe treatment on biochemical parameters other than lipid parameters, 8th National Internal Medicine Congress, 13-17 Sept 2006, Antalya.
17. Küçükkaya B., Erdem L., Derviş G., Demirci R., Bilir B., Kahraman C., Şendağ D.: Changes in lipid profile and uric acid levels and their relationships in hyperlipidemic patients treated with ezetimibe, 8th National Internal Medicine Congress, 13-17 Sept 2006, Antalya.
18. Küçükkaya B., Kahraman C., Ekiz B., Özcaan A., Şendağ D.: Changes in HSCRP and CRP levels and their relationships in hyperlipidemic patients treated with atorvastatin, 8th National Internal Medicine Congress, 13-17 Sept 2006, Antalya.
19. Sertbaş Y., Küçükkaya B., Canbulat E.C., Kahraman C., Karabulut S., Ayter M., Şendağ D.: Effects of ezetimibe treatment on bone mineral density and metabolic markers in hyperlipidemic patients, Adv. in Molecular Biol., 3(3): 105-106, 2007.
20. Kandemir M., Küçükkaya B., Tepe M.S., Yalçıner Z.B., Salepçi N.T.: Reversible Posterior Leukoencephalopathy Syndrome Due to Carboplatin and Paclitaxel Therapy, Balkan Medical Journal, Volume 32 Issue 4, October 2015.

Oral Presentations:

1. Yalçın A.S., Küçükkaya B., Haklar G.: Reactive oxygen species, central nervous system disorders, and glutamate excitotoxicity, International Congress on Free Radicals in Health and Disease, September 6-10, 1995, Istanbul, Turkey.
2. Yalçın A.S., Haklar G., Küçükkaya B.: Chemiluminescence measurements for the detection of free radical species, in Institute co-sponsored by FEBS and NATO “Free radicals, oxidative stress, and antioxidants: Pathological and physiological significance,” May 1997, Antalya, Turkey.
3. Yalçın A.S., Haklar G., Küçükkaya B.: The role of free radicals in NMDA and glutamate excitotoxicity, in Institute co-sponsored by FEBS and NATO “Free radicals, oxidative stress, and antioxidants: Pathological and physiological significance,” May 1997, Antalya, Turkey.
4. Gogas D., Ersöz Ö., Budak Y., Küçükkaya B., Gümüş A., Emerk K., Akalın S.: Effects of aminoguanidine on erythrocytes’ anionic charges and sialic acid levels in a diabetic rat model, XX National Congress of Endocrinology and Metabolic Diseases (with international participation), September 1997, Izmir, Turkey.
5. Ayter M., Küçükkaya B., Erbilgin N., Güven Ö.: Lymphomas and Hodgkin’s Disease, Anadolu Group Internal Medicine Meeting, 24 February 2005, Istanbul.